Statement on Authorization Pfizer’s COVID

FOR IMMEDIATE RELEASE Doctors for America PO Box: 21161 2300 18th St NW Lbby Washington, DC 20009-9996 August 18, 2025 Physicians Urge FDA to Maintain Authorization of Pfizer’s COVID-19 Vaccine for Children WASHINGTON, D.C. – Today Doctors for America Food and Drug Administration (FDA) Task Force is urging the FDA to preserve the emergency use authorization (EUA) of Pfizer’s COVID-19 vaccine for children younger than 5 years old, and sounding the alarm that revoking the EUA for the only vaccine approved for infants and young children puts young lives at unnecessary risk, undermines trust in the FDA and jeopardizes public health. Parents have had the freedom to choose to vaccinate their very young children in shared decision-making with their doctor since June 2022. COVID-19 hospitalization rates for very young children are the same as for the elderly and the long-term effects of COVID-19 infection are just being recognized.COVID-19 remains a threat to children, particularly those with underlying health conditions, as well as to their families and communities. Removing access to this vaccine could not only leave children more vulnerable, it could reverse years of progress in preventing COVID-19 infections and severe outcomes. As physicians, our first responsibility is to protect the health and well-being of our patients, including young children. Revoking the authorization for this vaccine that has consistently proven to be safe and effective will not only harm patients but could create confusion among parents and weaken public confidence in childhood immunizations. DFA’s FDA Task Force urges FDA to reaffirm its commitment to evidence-based decision making and to the protection of public health by keeping the Pfizer COVID-19 vaccine available to all children. For press inquiries and to speak more on this issue with members of Doctors for America, please contact Alli Everton with Continuum Health Group ([email protected]). ### About Doctors for America: